SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
SAN
80.24
-1.64%↓
UCB
237.4
-3.73%↓
SHL.DE
35.42
-1.69%↓
ARGX
666.6
-2.49%↓
VIE
35.59
+0.08%↑
24h
Actual
Mínimo
111.55
Máximo
112.05
Ingresos | 250M 902M |
|---|---|
Ventas | 63M 5.3B |
Rentabilidad por dividendo | 1.34 |
Margen de beneficios | 16.961 |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +23.16% upside |
Rentabilidad por dividendo Media del Sector | 1.34% 2.24% |
|---|---|
Próximas Ganancias | 13 may 2026 |
Capitalización Mercado | 98B |
|---|---|
Apertura anterior | 111.65 |
Cierre anterior | 111.65 |
By Trading Central
Confianza
Strong Bearish Evidence
121.15 / 123.55 Soporte y Resistencia
Resultados pasados no son un indicador fiable de resultados futuros.
5 mar 2026, 06:28 UTC
Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings
DJ
Leer
13 nov 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Leer
13 nov 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Leer
1 abr 2026, 12:06 UTC
Merck KGaA Completes Acquisition of JSR Life Sciences' Chromatography Business
DJ
Leer
5 mar 2026, 08:40 UTC
Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8
DJ
Leer
5 mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Sales EUR20B-EUR21B
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Adj EPS EUR8.34
DJ
Leer
5 mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20 a Share
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA 2025 After-Tax Profit EUR2.615B
DJ
Leer
5 mar 2026, 06:00 UTC
Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Sales EUR21.1B
DJ
Leer
5 mar 2026, 06:00 UTC
Merck KGaA 2025 Ebitda Before Special Items EUR6.11B
DJ
Leer
12 feb 2026, 15:20 UTC
Sanofi Shares Fall After CEO Change -- Update
DJ
Leer
20 ene 2026, 09:54 UTC
DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk
DJ
Leer
13 nov 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Leer
13 nov 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 Meses
Media 138 EUR 23.16%
Máximo 152 EUR
Mínimo 112 EUR
De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.
By TipRanks
Comprar
8 ratings
5
Comprar
3
Mantener
0
Vender
De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Merck KGaA Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Medio plazo
Neutral Evidence
The bullish and bearish events are balanced.
Largo Plazo
Bearish Evidence
All events are bearish.
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$